C12Y 304/21009
Enteropeptidase , i.e. enterokinase
Official title: Enteropeptidase (3.4.21.9), i.e. enterokinase
C12Y304/21009 (Enteropeptidase , i.e. enterokinase) appears on 16 US grants and 25 published applications in this corpus.
Search patents in C12Y- Granted patents
- 16
- Published applications
- 25
- Assignees
- 18
- Inventors
- 64
- Latest grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 4 |
| 2016 | 0 | 2 |
| 2017 | 1 | 0 |
| 2018 | 3 | 2 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 1 | 3 |
| 2024 | 3 | 2 |
| 2025 | 3 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treating cancer20 May 2025US 12,305,171 B2bioAffinity Technologies, Inc.
- Method for screening protease variant and obtained protease variant8 Apr 2025US 12,270,124 B2Shangrao Concord Pharmaceutical Co., Ltd.
- Host cells comprising a recombinant casein protein and a recombinant kinase protein4 Mar 2025US 12,241,109 B2Nobell Foods, Inc.
- Host cells comprising a recombinant casein protein and a recombinant kinase protein12 Nov 2024US 12,139,737 B2Nobell Foods, Inc.
- Food compositions comprising recombinant milk proteins3 Sep 2024US 12,077,798 B2Nobell Foods, Inc.
- Method for producing polypeptide from recombinant fusion protein and use thereof2 Jul 2026US 2026/0184756 A1Guangdong Zeta Pharmaceutical Co., Ltd.
- Compositions and Methods for Treating Cancer20 Nov 2025US 2025/0354156 A1bioAffinity Technologies, Inc.
- Food compositions comprising recombinant milk proteins12 Jun 2025US 2025/0188507 A1Nobell Foods, Inc.
- Host cells comprising a recombinant casein protein and a recombinant kinase protein9 Jan 2025US 2025/0011828 A1Nobell Foods, Inc.
- Food compositions comprising recombinant milk proteins28 Mar 2024US 2024/0102072 A1Nobell Foods, Inc.
Most cited
By later US patents
- Methods for control of flux in metabolic pathways through protease manipulation27US 8,916,358 B2GreenLight Biosciences, Inc. · 2014
- Recombinant cellular iysate system for producing a product of interest19US 10,036,001 B2GreenLight Biosciences, Inc. · 2018
- Production of biologically active proteins10US 8,163,880 B2Era Biotech, S.A. · 2012
- Host cells comprising a recombinant casein protein and a recombinant kinase protein5US 11,840,717 B2Nobell Foods, Inc. · 2023
- Fusion partners for peptide production2US 10,118,956 B2Pfenex Inc. · 2018